Moreover, CPT1A lowers the risk of cancer recurrence and metastasis, reduces mortality, and offers prospective therapy options for clinical treatment if the effects of CPT1A on the lipid metabolism of cancer cells are inhibited [8]. The gene discussed is CPT1A; the disease is cancer.